You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Simultaneous Assessment of Myocardial Scar and Coronary Arteries Using Navigator-Gated 3-Dimensional Fat-Suppressed Delayed-Enhancement MRI at 3.0 T: A Technical Feasibility Study

Amano, Yasuo MD; Kiriyama, Tomonari MD; Kobayashi, Yasuhiro MD; Tachi, Masaki MD; Matsumura, Yoshio RT; Kumita, Shinichiro MD

Journal of Computer Assisted Tomography:
doi: 10.1097/RCT.0b013e3182455cca
Cadiovascular Imaging
Abstract

Objective: To assess technical feasibility of navigator-gated 3-dimensional (3D) fat-suppressed delayed-enhancement magnetic resonance imaging (DE-MRI) at 3.0 T for simultaneous visualization of myocardial scars and coronary arteries.

Methods: Thirty patients with various myocardial diseases underwent navigator-gated 3D fat-suppressed DE-MRI using a 3.0-T scanner. The ability of this imaging technique to detect myocardial scars was compared with that of 2D DE-MRI. Visualization of the coronary arteries by this MRI technique was scored, and the relationship between myocardial scars and coronary arteries was assessed.

Results: Navigator-gated 3D fat-suppressed DE-MRI detected 71 of 75 segments with a myocardial scar. This imaging visualized proximal coronary arteries with an acceptable image quality and demonstrated a relationship between the myocardial scars and coronary arteries in 11 of the patients with scars.

Conclusion: Navigator-gated 3D fat-suppressed DE-MRI at 3.0 T was feasible for simultaneous visualization of myocardial scars and proximal coronary arteries.

Author Information

From the Department of Radiology, Nippon Medical School, Tokyo, Japan.

Received for publication August 28, 2011; accepted December 6, 2011.

Reprints: Dr. Yasuo Amano, MD, Department of Radiology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan (e-mail: yas-amano@nifty.com).

The authors report no conflicts of interest.

Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved.